Ramazan Durmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramazan Durmaz has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
E Tel
4 shared publicationsEşref Tel
4 shared publicationsA Arslantaş
2 shared publications- Ali Arslantas
Department of Neurosurgery, University of Osmangazi, Eskisehir, Turkey
2 shared publications Ali Arslantaş
2 shared publicationsEmre Ozkara
2 shared publications
Latest Publications
- 1 July 2014
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 122, 66-69
Early decompressive surgery after combined intra-venous thrombolysis and endovascular stroke treatment
- 1 July 2014
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 122, 66-69
Early decompressive surgery after combined intra-venous thrombolysis and endovascular stroke treatment
- 1 January 2009
- Vol. 19 (1) , 91-95
Symptomatic Foraminal Extradural Meningeal Cyst
The authors described the case of a 39-year-old man with Klippel-Trenaunay syndrome, who had an extradural meningeal cyst expanding into intervertebral foramen of lumbar 2 and 3 vertebrae. The patient suffered from low back pain radiating to the left lower extremity. Magnetic resonance imaging revealed a huge extradural meningeal cyst growing through intervertebral foramen far laterally. A widened neural foramen of L2 and L3 vertebrae was observed oil his plain radiography. The cyst was totally excised after tying the ostium connecting the subarachnoid space of the dural sac. This case supports the congenital theory in the pathogenesis of spinal cysts because the Klippel-Trenaunay syndrome is a congenital disorder including a mesodermal abnormality which may be the causative factor for a congenital defect in dura.
- 1 January 2009
- Vol. 19 (1) , 91-95
Symptomatic Foraminal Extradural Meningeal Cyst
The authors described the case of a 39-year-old man with Klippel-Trenaunay syndrome, who had an extradural meningeal cyst expanding into intervertebral foramen of lumbar 2 and 3 vertebrae. The patient suffered from low back pain radiating to the left lower extremity. Magnetic resonance imaging revealed a huge extradural meningeal cyst growing through intervertebral foramen far laterally. A widened neural foramen of L2 and L3 vertebrae was observed oil his plain radiography. The cyst was totally excised after tying the ostium connecting the subarachnoid space of the dural sac. This case supports the congenital theory in the pathogenesis of spinal cysts because the Klippel-Trenaunay syndrome is a congenital disorder including a mesodermal abnormality which may be the causative factor for a congenital defect in dura.
- 1 October 2008
- Vol. 18 (4) , 336-44
Efficacy of prognostic factors on survival in patients with low grade glioma.
In this report, we aim to determine the prognostic factors influencing the length of survival in patients with low-grade gliomas. In a retrospective evaluation, we have reviewed fiftythree patients who had been operated between the years of 1980 and 2006. The diagnoses of the patients were histopathologically verified as low-grade glioma(LGG). The medical records of the patients were reviewed for age, gender, tumor locations, extent of resection, and presence of seizure, the neurological status as defined by the Karnofsky Performance Scale (KPS) and radiotherapy treatment after surgery as possible prognostic factors. Median cumulative survival time for all the patients with LGG was 141+/-14.83 months. Median survival time was 216+/-78.52 months for astrocytoma Grade I; 115+/-8.22 months for astrocytoma Grade II, and 242+/-76.36 months for oligodendroglioma. Young age, histology subtype (oligodendroglioma) and preoperative KPS were determined to have positive influence on survival according to Log Rank Test. In contrast, age, histology type and the extent of resection remained independent prognostic factors upon survival when Cox Regression Backward Stepwise (Wald) method was performed. It can be concluded that surgery seems to be an appropriate first step option in the treatment of LGG.
- 1 October 2008
- Vol. 18 (4) , 336-44
Efficacy of prognostic factors on survival in patients with low grade glioma.
In this report, we aim to determine the prognostic factors influencing the length of survival in patients with low-grade gliomas. In a retrospective evaluation, we have reviewed fiftythree patients who had been operated between the years of 1980 and 2006. The diagnoses of the patients were histopathologically verified as low-grade glioma(LGG). The medical records of the patients were reviewed for age, gender, tumor locations, extent of resection, and presence of seizure, the neurological status as defined by the Karnofsky Performance Scale (KPS) and radiotherapy treatment after surgery as possible prognostic factors. Median cumulative survival time for all the patients with LGG was 141+/-14.83 months. Median survival time was 216+/-78.52 months for astrocytoma Grade I; 115+/-8.22 months for astrocytoma Grade II, and 242+/-76.36 months for oligodendroglioma. Young age, histology subtype (oligodendroglioma) and preoperative KPS were determined to have positive influence on survival according to Log Rank Test. In contrast, age, histology type and the extent of resection remained independent prognostic factors upon survival when Cox Regression Backward Stepwise (Wald) method was performed. It can be concluded that surgery seems to be an appropriate first step option in the treatment of LGG.
- 11 April 2008
- Published by Springer Nature in Neurochemical Research
- Vol. 33 (9) , 1683-1691
The Protective Effect of Dexanabinol (HU-211) on Nitric Oxide and Cysteine Protease-Mediated Neuronal Death in Focal Cerebral Ischemia
We hypothesized that dexanabinol can prevent neuronal death by protecting neuronal lysosomes from nitric oxide (NO)-mediated toxicity, and in turn, by suppressing the release of cathepsins during cerebral ischemia. Focal cerebral ischemia was induced in two sets of animals by permanent middle cerebral artery occlusion. The first set was used to monitor NO concentration and cathepsin activity, while the second was used for histological examination with hematoxylin and eosin, and TUNEL staining. In post-ischemic brain tissue, NO content and cathepsin B and L activity increased (p < 0.05). Dexanabinol treatment reduced NO concentration and cathepsin activity to the control level (p > 0.05). The number of eosinophilic and apoptotic neurons increased in the post-ischemic cerebral cortex (p < 0.05). However, dexanabinol treatment lowered both of these (p < 0.05). We conclude that dexanabinol might be a useful agent for the treatment of stroke patients.
- 11 April 2008
- Published by Springer Nature in Neurochemical Research
- Vol. 33 (9) , 1683-1691
The Protective Effect of Dexanabinol (HU-211) on Nitric Oxide and Cysteine Protease-Mediated Neuronal Death in Focal Cerebral Ischemia
We hypothesized that dexanabinol can prevent neuronal death by protecting neuronal lysosomes from nitric oxide (NO)-mediated toxicity, and in turn, by suppressing the release of cathepsins during cerebral ischemia. Focal cerebral ischemia was induced in two sets of animals by permanent middle cerebral artery occlusion. The first set was used to monitor NO concentration and cathepsin activity, while the second was used for histological examination with hematoxylin and eosin, and TUNEL staining. In post-ischemic brain tissue, NO content and cathepsin B and L activity increased (p < 0.05). Dexanabinol treatment reduced NO concentration and cathepsin activity to the control level (p > 0.05). The number of eosinophilic and apoptotic neurons increased in the post-ischemic cerebral cortex (p < 0.05). However, dexanabinol treatment lowered both of these (p < 0.05). We conclude that dexanabinol might be a useful agent for the treatment of stroke patients.
- 1 April 2008
- Vol. 18 (2) , 157-164
Nitric oxide level and adenosine deaminase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage
OBJECTIVE: Adenosine and nitric oxide (NO) are known as vasodilatators. We investigated adenosine deaminase (ADA) activity and NO concentration in the cerebrospinal fluid (CSF) of patients with subarachnoid hemorrhage (SAH). METHODS: Forty patients with SAH and 10 controls were included in the study. Nitrate level and ADA activity were measured in CSF. SAH patients were grouped according to the presence of angiographic vasospasm, Hunt and Hess grading, Glasgow Coma Scale (GCS) and Fisher Grade (FG). RESULTS: The level of NO markers in SAH patients decreased when compared to that in the control group (p<0.05). However, NO markers in patients with vasospasm was higher than in that of patients without vasospasm (p<0.05). ADA activity increased in patients with SAH (p<0.01) and also patients with angiographic vasospasm (p<0.05). ADA activity in the poor-grade SAH group was higher than that in the good-grade SAH group. The group with the lower GCS showed increased ADA activity compared to those with a higher GCS score (p<0.01). Furthermore, patients with FG 4 had a higher level of ADA activity compared to FG 1 and 2 and FG 3 (p<0.001 and p<0.01, respectively). CONCLUSION: Decreased NO level may participate in the early development of vasospasm. However, the increased level of ADA activity in the SAH patients with the poor clinical and consciousness level may have resulted from the ischemic cerebral insult.
- 1 April 2008
- Vol. 18 (2) , 157-164
Nitric oxide level and adenosine deaminase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage
OBJECTIVE: Adenosine and nitric oxide (NO) are known as vasodilatators. We investigated adenosine deaminase (ADA) activity and NO concentration in the cerebrospinal fluid (CSF) of patients with subarachnoid hemorrhage (SAH). METHODS: Forty patients with SAH and 10 controls were included in the study. Nitrate level and ADA activity were measured in CSF. SAH patients were grouped according to the presence of angiographic vasospasm, Hunt and Hess grading, Glasgow Coma Scale (GCS) and Fisher Grade (FG). RESULTS: The level of NO markers in SAH patients decreased when compared to that in the control group (p<0.05). However, NO markers in patients with vasospasm was higher than in that of patients without vasospasm (p<0.05). ADA activity increased in patients with SAH (p<0.01) and also patients with angiographic vasospasm (p<0.05). ADA activity in the poor-grade SAH group was higher than that in the good-grade SAH group. The group with the lower GCS showed increased ADA activity compared to those with a higher GCS score (p<0.01). Furthermore, patients with FG 4 had a higher level of ADA activity compared to FG 1 and 2 and FG 3 (p<0.001 and p<0.01, respectively). CONCLUSION: Decreased NO level may participate in the early development of vasospasm. However, the increased level of ADA activity in the SAH patients with the poor clinical and consciousness level may have resulted from the ischemic cerebral insult.
- 7 February 2008
- Published by Springer Nature in Neurosurgical Review
- Vol. 31 (2) , 215-223
Dexanabinol prevents development of vasospasm in the rat femoral artery model
We postulated that a multi-potential agent such as dexanabinol may prevent the development of vasospasm after subarachnoid hemorrhage. We tested the effect of dexanabinol (10 mg/kg) on established vasospasm in a rat femoral artery model. Dexanabinol was given as single or repeated doses. On the 7th day after blood application, vessels were prepared for transmission electron microscopy studies, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling staining, and studying vessel morphology including luminal area and wall thickness. Application of blood to femoral artery caused a significant narrowing of luminal area (p < 0.001) and a marked increase of radial wall thickness (p < 0.001) when compared to controls. Similar to its single injection, repeated doses of dexanabinol markedly widened luminal area (p < 0.001) near to control values (p > 0.05) and decreased radial wall thickness significantly compared to hemorrhage (p < 0.05) and vehicle-treated groups (for single p < 0.05 and repetitive injections p < 0.01). Both single and multiple dexanabinol injections also lowered apoptotic index (p < 0.001). In conclusion, dexanabinol seems to prevent established vasospasm and endothelial cell apoptosis.
- 7 February 2008
- Published by Springer Nature in Neurosurgical Review
- Vol. 31 (2) , 215-223
Dexanabinol prevents development of vasospasm in the rat femoral artery model
We postulated that a multi-potential agent such as dexanabinol may prevent the development of vasospasm after subarachnoid hemorrhage. We tested the effect of dexanabinol (10 mg/kg) on established vasospasm in a rat femoral artery model. Dexanabinol was given as single or repeated doses. On the 7th day after blood application, vessels were prepared for transmission electron microscopy studies, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling staining, and studying vessel morphology including luminal area and wall thickness. Application of blood to femoral artery caused a significant narrowing of luminal area (p < 0.001) and a marked increase of radial wall thickness (p < 0.001) when compared to controls. Similar to its single injection, repeated doses of dexanabinol markedly widened luminal area (p < 0.001) near to control values (p > 0.05) and decreased radial wall thickness significantly compared to hemorrhage (p < 0.05) and vehicle-treated groups (for single p < 0.05 and repetitive injections p < 0.01). Both single and multiple dexanabinol injections also lowered apoptotic index (p < 0.001). In conclusion, dexanabinol seems to prevent established vasospasm and endothelial cell apoptosis.
- 1 January 2008
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 13 (3) , 217-226
AA-861 appears to suppress leukocyte infiltration induced by traumatic brain injury in rats
OBJECTIVE: To study the effect of 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA-861) on intercellular adhesion molecule 1 (ICAM-1) and P-selectin expression, leukotriene B4 (LTB4) level, and myeloperoxidase (MPO) activity 24 hours after traumatic brain injury (TBI). METHODS: This study was carried out in the laboratory of the Department of Clinical Pharmacology, Osmangazi University, Eskisehir, Turkey in 2006. Traumatic brain injury was induced in 2 sets of animals using Feeney’s weight-drop method. The first set was used to study the expression of ICAM-1, P-selectin, CD11a, and mouse anti-rat granulocyte monoclonal antibody (HIS48). The second was used to study tissue changes in LTB4 level, and MPO activity. The rats were sacrificed at 0.5, 4, 24, 48, and 72 hours post-injury. RESULTS: Intercellular adhesion molecule (p=0.000001) and P-selectin expression (p=0.00002) peaked at 24 hours, remained high at 48 hours (p=0.00012 for ICAM-1, and p=0.00002 for P-selectin), and 72 hours (p=0.000008 for ICAM-1, p=0.0011 for P-selectin). The HIS48 intensity was significantly increased at 24-72 hours (p=0.022), while the intensity of CD11a became significant only at 72 hours (p=0.040). Myeloperoxidase activity increased notably at 24 hours (p=0.00077), and peaked at 48 hours (p=0.00001). The LTB4 increased markedly at 4 hours (p=0.000004), and peaked at 24 hours (p=0.000001). Pretreatment with AA-861 considerably suppressed the expression of ICAM-1 (p=0.0053), and P-selectin (p=0.0018) on microvascular endothelium, and lowered MPO activity (p=0.0007), and LTB4 level (p=0.008) at 24 hours. CONCLUSION: The present results suggest that AA-861 might be a potential mediator in the treatment of brain inflammation in TBI.
- 1 January 2008
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 13 (3) , 217-226
AA-861 appears to suppress leukocyte infiltration induced by traumatic brain injury in rats
OBJECTIVE: To study the effect of 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA-861) on intercellular adhesion molecule 1 (ICAM-1) and P-selectin expression, leukotriene B4 (LTB4) level, and myeloperoxidase (MPO) activity 24 hours after traumatic brain injury (TBI). METHODS: This study was carried out in the laboratory of the Department of Clinical Pharmacology, Osmangazi University, Eskisehir, Turkey in 2006. Traumatic brain injury was induced in 2 sets of animals using Feeney’s weight-drop method. The first set was used to study the expression of ICAM-1, P-selectin, CD11a, and mouse anti-rat granulocyte monoclonal antibody (HIS48). The second was used to study tissue changes in LTB4 level, and MPO activity. The rats were sacrificed at 0.5, 4, 24, 48, and 72 hours post-injury. RESULTS: Intercellular adhesion molecule (p=0.000001) and P-selectin expression (p=0.00002) peaked at 24 hours, remained high at 48 hours (p=0.00012 for ICAM-1, and p=0.00002 for P-selectin), and 72 hours (p=0.000008 for ICAM-1, p=0.0011 for P-selectin). The HIS48 intensity was significantly increased at 24-72 hours (p=0.022), while the intensity of CD11a became significant only at 72 hours (p=0.040). Myeloperoxidase activity increased notably at 24 hours (p=0.00077), and peaked at 48 hours (p=0.00001). The LTB4 increased markedly at 4 hours (p=0.000004), and peaked at 24 hours (p=0.000001). Pretreatment with AA-861 considerably suppressed the expression of ICAM-1 (p=0.0053), and P-selectin (p=0.0018) on microvascular endothelium, and lowered MPO activity (p=0.0007), and LTB4 level (p=0.008) at 24 hours. CONCLUSION: The present results suggest that AA-861 might be a potential mediator in the treatment of brain inflammation in TBI.
- 1 November 2003
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 215 (1-2) , 87-93
Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury
- 1 November 2003
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 215 (1-2) , 87-93
Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury
- 1 December 2001
- Vol. 45 (4) , 202
Instrumentation for posterior stabilisation of cervical traumatic and degenerative disorders: bullet-shaped implant and titanium cable.
Numerous implants for posterior stabilisation of cervical spine have been described so far. The aims of all these implants and techniques are rigid spinal stabilisation without neurologic damage, restoration of neuroanatomy and excellent radiological studies in postoperative period. The objective of this study was to determine the effectively and clinical safety of this system. We conducted a retrospective analysis of patients treated with posterior stabilisation system for the stabilisation of traumatic and osteodegerative disorders of lower cervical spine in our department. This posterior cervical stabilisation system consist of titanium bullet-shaped implant (Ti-Frame) and titanium cables (sof' wire). All patients underwent only posterior fixation except 2 (anterior decompression and posterior stabilisation in 2 stages) and postoperative early immobilisation was allowed with Philadelphia collar in all patients. At the follow-up period 15.2 months (9-25 months), none of the patients had superficial or deep infection, implant resection or failure. In conclusion, this system (Ti-frame and titanium cables) is a simple, safe and effective system for posterior cervical stabilisation in patients with traumatic and osteodegenerative disorders due to provide rigid fixation and allow CT and MR imaging without the significant artifact.
- 1 December 2001
- Vol. 45 (4) , 202
Instrumentation for posterior stabilisation of cervical traumatic and degenerative disorders: bullet-shaped implant and titanium cable.
Numerous implants for posterior stabilisation of cervical spine have been described so far. The aims of all these implants and techniques are rigid spinal stabilisation without neurologic damage, restoration of neuroanatomy and excellent radiological studies in postoperative period. The objective of this study was to determine the effectively and clinical safety of this system. We conducted a retrospective analysis of patients treated with posterior stabilisation system for the stabilisation of traumatic and osteodegerative disorders of lower cervical spine in our department. This posterior cervical stabilisation system consist of titanium bullet-shaped implant (Ti-Frame) and titanium cables (sof' wire). All patients underwent only posterior fixation except 2 (anterior decompression and posterior stabilisation in 2 stages) and postoperative early immobilisation was allowed with Philadelphia collar in all patients. At the follow-up period 15.2 months (9-25 months), none of the patients had superficial or deep infection, implant resection or failure. In conclusion, this system (Ti-frame and titanium cables) is a simple, safe and effective system for posterior cervical stabilisation in patients with traumatic and osteodegenerative disorders due to provide rigid fixation and allow CT and MR imaging without the significant artifact.
- 1 April 2001
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 103 (1) , 59-62
Multiple nocardial abscesses of cerebrum, cerebellum and spinal cord, causing quadriplegia
- 1 April 2001
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 103 (1) , 59-62
Multiple nocardial abscesses of cerebrum, cerebellum and spinal cord, causing quadriplegia